Fuller’s Discloses New External Directorship for Board Member

Fuller Smith & Turner ( (GB:FSTA) ) has shared an announcement.

Fuller, Smith & Turner has announced that independent non-executive director Jane Bednall will take on an additional role as an independent non-executive director at CVS Group, effective 1 April 2026. The move underscores Fuller’s adherence to U.K. corporate governance disclosure rules, signalling that the company continues to evolve its boardroom connections while maintaining regulatory transparency for shareholders and the wider market.

The most recent analyst rating on (GB:FSTA) stock is a Buy with a £847.00 price target. To see the full list of analyst forecasts on Fuller Smith & Turner stock, see the GB:FSTA Stock Forecast page.

Spark’s Take on FSTA Stock

According to Spark, TipRanks’ AI Analyst, FSTA is a Outperform.

Fuller Smith & Turner demonstrates strong technical momentum and positive corporate actions, which are the most significant factors driving the score. Financial performance is solid, though improvements in free cash flow and return on equity could enhance the outlook. Valuation is fair, providing a balanced risk-reward profile.

To see Spark’s full report on FSTA stock, click here.

More about Fuller Smith & Turner

Fuller, Smith & Turner P.L.C., known as Fuller’s, is a U.K.-listed company traditionally associated with pubs, hospitality and brewing. It operates as a public limited company on the London market and is subject to U.K. listing rules governing corporate governance, including oversight of its board and independent non-executive directors.

Average Trading Volume: 34,560

Technical Sentiment Signal: Buy

Current Market Cap: £346.6M

Find detailed analytics on FSTA stock on TipRanks’ Stock Analysis page.